gradual but steady increasein infections.
The national
rT— the metric that tracks the average number of people one infected person subsequently will infect — is now over one. That means the pandemic is again in growth mode.
Pointing to early findings from South Africa, where omicron was first identified and case counts have skyrocketed, PHAC said cases could quadruple to 12,000 a day in January if
omicron successfully establishesand the current levels of transmission are maintained.
Omicron’s
greater transmissibilityand the potential for
reduced protection from prior infection/vaccinationcould drive this resurgence, PHAC said. The effectiveness of the current slate of COVID-19 vaccines against omicron is still under review.
As of December 9, there have been 87 confirmed cases of omicron reported in seven Canadian jurisdictions. To date, all reported cases of omicron in Canada have been asymptomatic or mild.
Even without omicron circulating widely, PHAC modelling suggests Canada could still be grappling with another wave of delta cases in the new year.
If the current level of transmission is maintained, cases stand to double to between 6,000 and 7,000 a day in January. If transmission levels increase, a delta-driven wave of roughly 12,000 cases a day is also possible, PHAC said.
Canadians between the ages of 5 and 11 are the most likely to contract COVID-19 right now given the low vaccine coverage in this demographic. The infection rate among kids aged 5 to 11 is over 20 cases per 100,000 people — four times higher than the rate for any other age group.
New outbreaks reported in schools
Hundreds of new COVID outbreaks have been reported in the nation’s schools and child care centres in recent weeks, driving up the infection rate for kids under 12.
COVID-19 cases in children often do not involve severe illness. To date, PHAC said, there have been over 380,000 reported cases in children and youths up to 19 years of age, with less than one per cent involving severe illness.
PHAC said the best way to blunt the spread of the virus is to ramp up the immunization campaign for people 5 to 11 and roll out third doses for other age groups.